Regulatory T Cells Increase After Rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children
Overview
Authors
Affiliations
Background: Myelin oligodendrocytes glycoprotein (MOG) antibody-associated disease (MOGAD) represent 25% of pediatric acquired demyelinating syndrome (ADS); 40% of them may relapse, mimicking multiple sclerosis (MS), a recurrent and neurodegenerative ADS, which is MOG-Abs negative.
Aims: To identify MOG antigenic immunological response differences between MOGAD, MS and control patients, and between relapsing non-relapsing subgroups of MOGAD.
Methods: Three groups of patients were selected: MOGAD (n=12 among which 5 relapsing (MOGR) and 7 non-relapsing (MOGNR)), MS (n=10) and control patients (n=7). Peripheral blood mononuclear cells (PBMC) collected at the time of the first demyelinating event were cultured for 48 h with recombinant human (rh)-MOG protein (10 μg/ml) for a specific stimulation or without stimulation as a negative control. The T cells immunophenotypes were analyzed by flow cytometry. CD4 T cells, T helper (Th) cells including Th1, Th2, and Th17 were analyzed by intracellular staining of cytokines. Regulatory T cells (T, Foxp3), CD45RAFoxp3 T and subpopulation naive T (CD45RAFoxp3), effector T (CD45RAFoxp3) and non-suppressive T (CD45RAFoxp3) proportions were determined.
Results: The mean onset age of each group, ranging from 9.9 to 13.8, and sex ratio, were similar between MOGR, MOGNR, MS and control patients as analyzed by one-way ANOVA and Chi-square test. When comparing unstimulated to rh-MOG stimulated T cells, a significant increase in the proportion of Th2 and Th17 cells was observed in MOGAD. Increase of Th17 cells was significant in MOGNR (means: 0.63 ± 0.15 1.36 ± 0.43; Wilcoxon-test = 0.03) but not in MOGR. CD4 T were significantly increased in MOGNR (means: 3.51 ± 0.7 4.59 ± 1.33; Wilcoxon-test = 0.046) while they decreased in MOGR. CD45RAFoxp3 T were significantly decreased in MOGR (means: 2.37 ± 0.23 1.99 ± 0.17; paired t-test = 0.021), but not in MOGNR. MOGR showed the highest ratio of effector T/non suppressive-T which was significantly higher than in MOGNR.
Conclusions: Our findings suggest that CD4 Th2 and Th17 cells are involved in the pathophysiology of MOGAD in children. The opposite response of T to rh-MOG in MOGNR, where CD4 T increased, and in MOGR, where CD45RAFoxp3 T decreased, suggests a probable loss of tolerance toward MOG autoantigen in MOGR which may explain relapses in this recurrent pediatric autoimmune disease.
Ryu G, Bae J, Yoo S, Kim E, Mo J Inflammation. 2025; .
PMID: 39753929 DOI: 10.1007/s10753-024-02227-8.
Georgopoulou E, Palkopoulou M, Liakopoulos D, Kerazi E, Kalaentzis A, Barmparoussi V Cureus. 2024; 16(9):e68946.
PMID: 39381468 PMC: 11461040. DOI: 10.7759/cureus.68946.
Liyanage G, Trewin B, Lopez J, Andersen J, Tea F, Merheb V J Neurol Neurosurg Psychiatry. 2024; 95(6):544-553.
PMID: 38290838 PMC: 11103329. DOI: 10.1136/jnnp-2023-332851.
Li X, Wu W, Hou C, Zeng Y, Wu W, Chen L Front Immunol. 2023; 14:1162647.
PMID: 37342342 PMC: 10277863. DOI: 10.3389/fimmu.2023.1162647.
Attack phenotypes and disease course in pediatric MOGAD.
Santoro J, Beukelman T, Hemingway C, Hokkanen S, Tennigkeit F, Chitnis T Ann Clin Transl Neurol. 2023; 10(5):672-685.
PMID: 37000895 PMC: 10187731. DOI: 10.1002/acn3.51759.